Furthermore, deltarasin was shown to decrease proliferation and increase apoptosis in KRAS mutated pancreatic tumor cells through the blockage of PDEδ–KRAS interaction, thus preventing their membrane localization in these cells. Here, KRAS is linked to pancreatic neoplasm.